Page 17 - டெல் தொழில்நுட்பங்கள் மூலதனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tetrate, the company born out of Istio s open source app networking project, raises $40 million – TechCrunch

Tetrate, the company born out of Istio s open source app networking project, raises $40 million – TechCrunch
techcrunch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from techcrunch.com Daily Mail and Mail on Sunday newspapers.

United statesNicolas chaillanUs department of defenseUs airSapphire venturesScale venture partnersDell technologies capitalIntel capitalLatin americaScrooge mcduckJai dasEnvoy proxyPlatform oneஒன்றுபட்டது மாநிலங்களில்எங்களுக்கு துறை ஆஃப் பாதுகாப்புஎங்களுக்கு அேக

The Movement to Transform Cancer Pathology with AI

Ibex said it will use proceeds from the series B round to support an expanding customer base of clinical deployments in labs and health systems in North America and Europe and grow talent across R&D, clinical and commercial teams. The firm said the investment will also accelerate the expansion of the Galen solution portfolio at Ibex, bringing new AI tools for more tissue types, including novel AI-based enhancements of the pathology workflow and oncology-focused AI-markers. Ibex is at the forefront of digital transformation in pathology and we are committed to supporting our customers on their AI journey, said Joseph Mossel, Ibex CEO and Co-founder. Quality diagnosis is our top priority and a cornerstone of cancer care programs. I am proud of our team, demonstrating through clinical studies and, more importantly, in live clinical settings, that our AI is a game-changer in eliminating misdiagnosis and ensuring real-time patient safety. This investment will help us meet t

Thomas jefferson university hospitalUnited statesSan franciscoTel avivJoseph mosselUniversity of californiaDermatopathology laboratory of central statesJohns hopkins school of medicineUniversity of floridaIbex medical analyticsSeriesb roundOctopus venturesPlanven entrepreneur venturesDell technologies capitalNorth americaJohns hopkins school

Ibex Medical Analytics scores $38M to power cancer diagnostics with AI

Results for Ibex Medical Analytics scores $38M to power cancer diagnostics with AI The Israeli medtech startup fuels its North American expansion. Ibex CEO: We view AI as the next great wave of transformation in healthcare . Dor Schwartz / 9 Mar 2021 • 3 min read The ongoing global pandemic has pushed healthcare services to the limit. From crowded hospitals to long diagnosis wait times, COVID has exposed many areas where healthcare may need a virtual hand, even in a post-COVID reality. One area where pathologists have previously struggled is in cancer diagnostics. It could be the lack of skilled personnel, backed up labs, or plain and simple, a rise in cases, but these workload issues can cause critical mishaps during the critical diagnosis process.

Puerto ricoUnited statesTel avivChaim linhartJoseph mosselGil gorenInstitut curieIbex medical analyticsNorth americaOctopus venturesPlanven entrepreneur venturesDell technologies capitalMedical analyticsGeneral partnerIbex boardப்வெர்டோ ரிக்கோ

Ibex Medical Analytics Raises $38 Million to Accelerate Adoption of AI-powered Cancer Diagnostics in Pathology

Ibex Medical Analytics Raises $38 Million to Accelerate Adoption of AI-powered Cancer Diagnostics in Pathology
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesYael hartJoseph mosselGil gorenMedical analyticsOctopus venturesPlanven entrepreneur venturesDell technologies capitalDell technologiesKamet venturesNorth americaWill gibbsIbex boardGeneral partnerஒன்றுபட்டது மாநிலங்களில்யேல் ஹார்ட்

Ibex Medical Analytics raises $38M for its AI-powered cancer diagnostic platform – TechCrunch

Ibex Medical Analytics raises $38M for its AI-powered cancer diagnostic platform Israel-based Ibex Medical Analytics, which has an AI-driven imaging technology to detect cancer cells in biopsies more efficiently, has raised a $38 million Series B financing round led by Octopus Ventures and 83North. Also participating in the round was aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital, the corporate venture arm of Dell Technologies. The company has now raised a total of $52 million since its launch in 2016. Ibex plans to use the investment to further sell into diagnostic labs in North America and Europe. Originally incubated out of the Kamet Ventures incubator, Ibex’s “Galen” platform mimics the work of a pathologist, allowing them to diagnose cancer more accurately and faster and derive new insights from a biopsy specimen.

United statesUnited kingdomChaim linhartJoseph mosselMichael niddamIsrael based ibex medical analyticsOctopus venturesPlanven entrepreneur venturesDell technologies capitalNorth americaKamet venturesஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்செய்ம் லின்ஹார்ட்இஸ்ரேல் அடிப்படையிலானது ஐபிக்ஸ் மருத்துவ பகுப்பாய்வுஆக்டோபஸ் முயற்சிகள்